Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Lymphoblastic Leukemia
Related studies linked through entity extraction aliases.
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment While Minimizing High Exposures That Impose Increased Risk of Side Effects Such as Hyperammonemia
- Status
- RECRUITING
- Phase
- N/A
A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, and Mixed Phenotype Acute Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy
- Status
- RECRUITING
- Phase
- NA
ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
- Status
- RECRUITING
- Phase
- NA
Treatment for Ph-negative ALL for Adults up to 65 Years
- Status
- NOT_YET_RECRUITING
- Phase
- NA
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- NA
A Study of Revumenib and Mezigdomide in People With Leukemia
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and Improve Frailty Outcomes
- Status
- RECRUITING
- Phase
- NA
Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A